available clinical research in the care of patients with nsclc with an egfr mutation
Published 2 months ago • 276 plays • Length 1:59:49Download video MP4
Download video MP3
Similar videos
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
2:03:23
current and future management of non-small cell lung cancer with an egfr mutation
-
8:52
from clinic to practice in nsclc patients with exon 20 mutations
-
14:30
adjuvant therapy for egfr mutant nsclc
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
58:47
15 years of advances in egfr mutant lung cancer
-
6:14
neoadjuvant ipilimumab plus nivolumab improves outcomes in resectable advanced melanoma
-
20:38
future research and treatment options | 2023 living with egfr-mutant lung cancer patient forum
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
28:28
patient selection, therapeutic sequencing, & treatment selection in egfr mutation-positive nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
37:23
nsclc: integrating egfr-inhibiting therapies into clinical pathways for first-line treatment
-
39:35
egfr mutation analysis
-
34:23
management of non-small cell lung cancer (nsclc) with an egfr mutation — karen reckamp, md, ms
-
20:35
tki-resistant egfr-mutant nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
0:48
new standard of care for lung cancer patients with egfr mutations